Neuropsychology
Neuropsychological assessment guides diagnosis and care planning across multiple neurological conditions. The session covers cognitive screening tools (MMSE, MoCA, ACE-III), dementia diagnosis pathway including subtype differentiation, MCI assessment and progression markers, post-stroke cognitive screening, computerised testing platforms (Cogstate, NeuroTrax), and neuropsychology in rehabilitation settings. Discussion addresses cultural and linguistic adaptation of neuropsychological tests, telehealth neuropsychology validation, performance validity testing, neuropsychology in epilepsy surgery workup, pediatric neuropsychology, and the role of neuropsychology in psychiatric differential diagnosis.
- MMSE, MoCA, ACE-III screening
- Dementia subtype differentiation
- MCI progression markers
- Post-stroke cognition
- Computerised testing platforms
- Telehealth neuropsychology
- Cultural test adaptation
- Performance validity testing
Explore the full GCNN 2027 program
- 01Stroke & Cerebrovascular Disease
- 02Alzheimer’s & Dementia
- 03Multiple Sclerosis
- 04Parkinson’s & Movement Disorders
- 05Epilepsy
- 06Neuromuscular Disease
- 07Headache Medicine
- 08Neuro-Oncology
- 09Clinical Neuroscience & AI
- 10Spinal Cord Injury
- 11Traumatic Brain Injury
- 12Sleep Disorders
- 13Neuropathic Pain
- 14Cerebellar & Ataxia Disorders
- 15Functional Neurological Disorders
- 16Pediatric Neurology
- 17Neuroimmunology
- 18Brain-Computer Interfaces
- 19Migraine
- 20Cluster Headache
- 21Dementia with Lewy Bodies
- 22Frontotemporal Dementia
- 23Huntington Disease
- 24ALS
- 25Tremor & Dystonia
- 26Restless Legs Syndrome
- 27Neuroinfectious Disease
- 28Brain Tumors
- 29Vestibular Disorders
- 30Autonomic Disorders
- 31Functional Imaging
- 32Neuro-Ophthalmology
- 34Movement Disorder Surgery
- 35Genetic Counselling